Omega Risk Solutions (Pty) Ltd v De Witt

Omega Risk Solutions (Pty) Ltd (the appellant) claimed various amounts from Josias Alexander De Witt (the respondent), who was the Chief Executive Officer of the Omega Group. The claims were based on payments made by the appellant between March 2007 and August 2010. The appellant alleged that the respondent had breached his fiduciary duty by: (1) authorizing payments to named individuals when the appellant was not liable to make such payments; (2) fraudulently misappropriating payments for personal purposes; and (3) authorizing payment to a company to discharge a personal liability. The respondent raised a special plea of prescription in respect of all claims except three payments. The central question was whether knowledge held by Mr Philippus Smit, an employee who was the Group Finance Manager (later Group Executive Finance), should be attributed to the appellant for purposes of prescription under sections 12(1) and 12(3) of the Prescription Act 68 of 1969. Mr Smit had oversight of group finances, supervised budgets and audits, consolidated financial statements monthly, managed cash flow, and was a member of the Executive Committee. He had knowledge of the minimum facts required to institute action within a period exceeding three years before summons was issued.

• Whether the claims advanced by the appellant had become prescribed in terms of sections 12(1) and 12(3) of the Prescription Act 68 of 1969
• Whether knowledge of the material facts held by Mr Smit, an employee of the appellant, could be attributed to the appellant for purposes of prescription
• What constitutes 'reasonable care' for purposes of the proviso to section 12(3) of the Prescription Act, which deems a creditor to have knowledge if it could have acquired it by exercising reasonable care
• Whether the board of directors of the appellant, acting reasonably and with due diligence, could have acquired knowledge of the facts from which the debt arose

The appeal was dismissed with costs, including the costs consequent upon the employment of two counsel. The High Court's decision upholding the special plea of prescription was affirmed.

For purposes of section 12(3) of the Prescription Act 68 of 1969, a corporate creditor is deemed to have knowledge of the facts from which a debt arises if the board of directors has such knowledge or could have acquired it by exercising reasonable care. Knowledge held by senior employees - particularly those responsible for financial management, oversight and reporting to the board - can constitute knowledge that the board could have acquired through reasonable care. The test is objective: what would a reasonable board of directors, acting with due diligence, have known in the circumstances. When payments that form the basis of claims: (1) involve substantial amounts; (2) extend over multiple auditing periods; (3) would appear in annual financial statements requiring board approval; (4) relate to transactions vital to the company's business; and (5) are known to senior financial personnel who consolidate financial statements and report to the board, then the board of directors could have acquired knowledge of the material facts by exercising reasonable care, and the creditor is deemed to have such knowledge for prescription purposes.

The court noted, without needing to decide the point, that it would be 'compellingly arguable' that on the facts the board of directors in fact knew and authorized the payments. The court also quoted with approval the statement from PriceWaterhouseCoopers v National Potato Co-operative that 'It is unnecessary for the purposes of this case to consider whether the knowledge of other persons within the entity would also be attributed to it for the purposes of prescription', indicating that while knowledge of board members clearly suffices, the question of attribution of knowledge from other persons within the entity remains open for future determination. The court referenced the policy underlying prescription as protecting defendants from undue delay by laggard litigants, providing context for the interpretation of section 12(3).

This case is significant in South African law for clarifying the application of section 12(3) of the Prescription Act 68 of 1969 to corporate creditors. It establishes important principles regarding when knowledge can be attributed to a company for prescription purposes, particularly: (1) the distinction between statutory attribution under section 12(3) (based on objective reasonable care) and common law rules of attribution; (2) that when prescription is raised against a corporate entity, the ordinary rule of attribution is satisfied if the board of directors has knowledge or could acquire it by taking reasonable care; (3) the test for constructive knowledge under section 12(3) is what a reasonable person in the creditor's position would have done, requiring reasonable care and diligence; (4) factors to consider include the seniority and functions of the employee with knowledge, the nature and quantum of payments, whether payments would appear in financial statements requiring board approval, and the importance of the relevant transactions to the company's business. The case reinforces the policy underlying prescription - to protect defendants from undue delay by laggard litigants - and confirms that companies cannot avoid prescription by claiming ignorance when senior financial personnel have knowledge of facts that would be apparent to a reasonably diligent board.